| Stage | FANG | % of rev | EOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $8.6B | 100.00% | EOG ×1.58 |
| Gross profit | $4.2B | 77.28% | $7.4B | 86.65% | EOG +9.4pp |
| Operating income | $2.5B | 46.03% | $3.5B | 41.21% | FANG +4.8pp |
| Pre-tax income | $2.3B | 41.83% | $3.5B | 40.87% | FANG +1.0pp |
| Net income | $1.8B | 32.61% | $2.7B | 31.81% | FANG +0.8pp |
| Stage | FANG | EOG | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $8.6B100.00% | EOG ×1.58 |
| Gross profit | 77.28%$4.2B | 86.65%$7.4B | EOG +9.4pp |
| Operating income | 46.03%$2.5B | 41.21%$3.5B | FANG +4.8pp |
| Pre-tax income | 41.83%$2.3B | 40.87%$3.5B | FANG +1.0pp |
| Net income |
| 32.61%$1.8B |
| 31.81%$2.7B |
| FANG +0.8pp |
No shared counterparties.